Erratum: Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Annals of Oncology (2010) 21(S5) (v198–v203), (S0923753419396565), (10.1093/annonc/mdq209));Soft tissue sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

Annals of Oncology

Volumn 21, Issue SUPPL. 5, 2010, Pages 1736-

  Casali, P G ^a   Blay, J Y ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; DACARBAZINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; GONADORELIN DERIVATIVE; IFOSFAMIDE; IMATINIB; INTERFERON; METHOTREXATE; NAVELBINE; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE DERIVATIVE; TAMOXIFEN; TAXANE DERIVATIVE; TOREMIFENE; TRABECTEDIN; VINBLASTINE;

ABDOMINAL HYSTERECTOMY; ANGIOSARCOMA; ARTICLE; BRACHYTHERAPY; BREAST SARCOMA; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER RELAPSE; CANCER STAGING; CLINICAL TRIAL; DERMATOFIBROSARCOMA PROTUBERANS; DISEASE FREE SURVIVAL; DRUG MEGADOSE; ENDOMETRIUM SARCOMA; EUROPE; FIBROMATOSIS; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LEIOMYOSARCOMA; LIPOSARCOMA; LOW DRUG DOSE; LUNG METASTASIS; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRACTICE GUIDELINE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; RETROPERITONEAL SARCOMA; SALPINGOOOPHORECTOMY; SOFT TISSUE SARCOMA; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYNOVIAL SARCOMA; UTERUS SARCOMA;

EID: 77954337682     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq419     Document Type: Erratum

References (21)

1. Amant F, Coosemans A, Debiec-Rychter M et al. Clinical management of uterine sarcomas. Lancet Oncol 2009, 10: 1188-1198
2. Antman K, Crowley J, Balcerzak SP et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993, 11: 1276-1285
3. Blackmon SH, Shah N, Roth JA et al. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 2009, 88: 877-884
4. Bonvalot S, Rivoire M, Castaing M et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol 2009, 27: 31-37
5. Demetri GD, Chawla SP, von Mehren M et al. Efficacy and safety of trabectedin in patients with advanced or metastatic liposarcoma or leiomyosarcoma after failure of prior anthracyclines and ifosfamide: results of a randomized phase II study of two different schedules. J Clin Oncol 2009, 27: 4188-4196.
6. Eggermont AMM. Isolated limb perfusion in the management of locally advanced extremity soft tissue sarcoma. Surg Oncol Clin N Am 2003, 12: 469-483
7. Fiore M, Rimareix F, Mariani L et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol 2009, 16: 2587-2593
8. Garcia-Carbonero R, Supko JG, Manola J et al. Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy. J Clin Oncol 2004, 22: 1480-1490
9. Gatta G, Ciccolallo L, Kunkler I et al. Survival from rare cancer in adults: a population-based study. EUROCARE Working Group. Lancet Oncol 2006, 7: 132-140
10. Gronchi A, Lo Vullo S, Fiore M et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol 2009, 27: 24-30
11. Grosso F, Jones RL, Demetri GD et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol 2007, 8: 595-602
12. Hensley ML, Maki R, Venkatraman E et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 2002, 20: 2824-2831
13. Janinis J, Patriki M, Vini L et al. The pharmacological treatment of aggressive fibromatosis: a systematic review. Ann Oncol 2003, 14: 181-190
14. Le Cesne A, Antoine E, Spielmann M et al. High-dose ifosfamide: circumvention of resistance to standard-dose ifosfamide in advanced soft tissue sarcomas. J Clin Oncol 1995, 13: 1600-1608
15. Maki RG, Wathen JK, Patel SR et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002. J Clin Oncol 2007, 25: 2755-2763
16. Penel N, Bui BN, Bay JO et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 2008, 26: 5269-5274
17. Pervaiz N, Colterjohn N, Farrokhyar F et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008, 113: 573-581
18. Reed NS, Mangioni C, Malmström H et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer 2008, 44: 808-818
19. Rutkowski P, Van Glabbeke M. Rankin CJ. Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials. J Clin Oncol 2010, Mar 1 [Epub ahead of print]
20. Soft tissue sarcoma. In American Joint Committee on Cancer. AJCC Cancer Staging Manual, 6th edition. New York: Springer 2002, 193-197
21. Trojani M, Contesso G, Coindre JM et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 1984, 33: 37-42